mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.007 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.009 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.009 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.009 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.009 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.009 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |